<SEC-DOCUMENT>0000849146-15-000084.txt : 20150811
<SEC-HEADER>0000849146-15-000084.hdr.sgml : 20150811
<ACCEPTANCE-DATETIME>20150810182511
ACCESSION NUMBER:		0000849146-15-000084
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150810
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150811
DATE AS OF CHANGE:		20150810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		151042093

	BUSINESS ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lifevantage-8xkearningsrel.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>8-K Q4 FY15 Preliminary Earnings Release</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s89E10A24DAC15136CAE3194057BBDA35"></a><div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><br><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:144%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">the Securities Exchange Act of 1934</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): August 10, 2015</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:24pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:110%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="32%"></td><td width="4%"></td><td width="30%"></td><td width="4%"></td><td width="30%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Colorado</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-35647</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90-0224471</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer Identification No.)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9785 S. Monroe Street, Suite 300, Sandy, UT 84070</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices and ZIP Code)</font></div></td></tr></table></div></div><div style="line-height:110%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:110%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (801)&#160;432-9000</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="7%"></td><td width="93%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:110%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><br><div><div style="line-height:120%;text-align:left;text-indent:720px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s89E10A24DAC15136CAE3194057BBDA35"></a><div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><br><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</font></div><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 10, 2015, LifeVantage Corporation (the &#8220;Company&#8221;) issued a press release announcing its preliminary financial results for the fiscal quarter and fiscal year ended June 30, 2015. A copy of the Company&#8217;s press release is attached as Exhibit 99.1 to this report and incorporated by reference.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</font></div><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) Exhibits </font></div><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:25px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.94017094017094%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="15%"></td><td width="3%"></td><td width="82%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;font-weight:bold;">Exhibit No.</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;font-weight:bold;">Description</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release issued by the Company on August 10, 2015 announcing its preliminary financial results for the fiscal quarter and fiscal year ended June 30, 2015.</font></div></td></tr></table></div></div><div style="line-height:130%;text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;text-indent:312px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><br><div><div style="line-height:120%;text-align:left;text-indent:720px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s89E10A24DAC15136CAE3194057BBDA35"></a><div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><br><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:144%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="50%"></td><td width="50%"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: August 10, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By: </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Beatryx Washington</font></div><div style="text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name: Beatryx Washington</font></div><div style="text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: Vice President, Legal Affairs</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:768px;font-size:18.5pt;"><font style="font-family:inherit;font-size:18.5pt;color:#002c40;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;text-indent:720px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lfvnq42015preannouncementd.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>99.1 Q4 FY15 Preliminary Earnings Release</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s0921F51E39CF7484A14A1956F033DF9B"></a><div><div style="line-height:120%;text-align:center;"><img src="lfvnq42015preannounce_image1.gif" style="height:58px;width:284px;"></div></div><br><div style="line-height:138%;text-align:center;font-size:14pt;"><font style="font-family:Arial;font-size:14pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:14pt;"><font style="font-family:Arial;font-size:14pt;font-weight:bold;">LifeVantage Announces Preliminary Fourth Quarter and Full Fiscal Year 2015 Results</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Fiscal Year 2015 Revenue and Earnings Per Share Results In-Line with Previous Guidance</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-style:italic;">Full Fiscal Year 2015 Revenue was Approximately $190 Million</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Salt Lake City, UT,</font><font style="font-family:Arial;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:12pt;font-weight:bold;">August 10, 2015</font><font style="font-family:Arial;font-size:12pt;">, LifeVantage Corporation (NASDAQ: LFVN) today announced preliminary results for the fourth quarter and full year ended June 30, 2015.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">For the fourth fiscal quarter ended June 30, 2015, the Company expects to report revenue of approximately $45 million, compared to $56 million for the same period of fiscal 2014.  The change in revenue was primarily due to a decline in revenue from Japan.  Operating income for the fourth quarter of 2015 was $1.5 million, compared to $4.7 million in the fourth fiscal quarter of 2014.   For the fourth fiscal quarter of 2015, the Company expects to realize earnings per diluted share of $0.00, calculated on 96.5 million fully diluted shares. This compares to $0.02 per diluted share, calculated on 105.6 million fully diluted shares, in the same period of fiscal 2014.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">For the full fiscal year ended June 30, 2015, the Company expects to report revenue of approximately $190 million, compared to $214 million in fiscal 2014. Operating income for full fiscal year 2015 was $13.9 million, compared to $19.5 million in the prior year period. For fiscal 2015, the Company expects diluted earnings per share of $0.07 per diluted share, calculated on 99.1 million fully diluted shares. This compared to $0.10 per diluted share, calculated on 111.6 million fully diluted shares, in fiscal 2014.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;background-color:#ffffff;">During the full year of fiscal</font><font style="font-family:Arial;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:12pt;">2015</font><font style="font-family:Arial;font-size:12pt;background-color:#ffffff;">, the</font><font style="font-family:Arial;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:12pt;">C</font><font style="font-family:Arial;font-size:12pt;background-color:#ffffff;">ompany reduced its overall debt to approximately $20.7 million from approximately $31 million. The</font><font style="font-family:Arial;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:12pt;">C</font><font style="font-family:Arial;font-size:12pt;background-color:#ffffff;">ompany ended fiscal</font><font style="font-family:Arial;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:12pt;">2015 </font><font style="font-family:Arial;font-size:12pt;background-color:#ffffff;">with approximately $13.9 million in cash and cash equivalents.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Darren Jensen, President and Chief Executive Officer of LifeVantage, stated, &#8220;Our fourth quarter and full fiscal year 2015 results were in-line with our previously issued guidance and we are well positioned to increase revenue and net income in fiscal 2016 compared to fiscal 2015.  Over the past several months, LifeVantage has undergone significant transitions, including me as the new CEO, the hiring of a new Chief Sales Officer, Justin Rose, and we enter fiscal 2016 with approximately $4 million of annual cost savings in order to better align our cost structure.    </font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="s0921F51E39CF7484A14A1956F033DF9B"></a><div><div style="line-height:120%;text-align:center;"><img src="lfvnq42015preannounce_image1.gif" style="height:58px;width:284px;"></div></div><br><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">I have spent my career in network marketing and LifeVantage has the attributes necessary to be a great growth company.  As we begin fiscal 2016, we are committed to improving our financial performance by increasing awareness of our products, more fully engaging our distributor base, and strategically expanding our geographic reach. With our new corporate leadership team in place, we have a refocused set of initiatives to return LifeVantage to aggressive top line growth.  We will be discussing our comprehensive new strategy to obtain this during our fourth quarter earnings conference call in September.&#8221;</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">The Company will provide further results in its complete fourth quarter and full year fiscal 2015 earnings release and conference call which are expected to occur on September 1, 2015.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">About LifeVantage Corporation</font></div><div style="line-height:138%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">LifeVantage Corporation (Nasdaq:LFVN), is a science based network marketing company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim</font><font style="font-family:Arial;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:Arial;font-size:12pt;">, the Nrf2 Synergizer</font><font style="font-family:Arial;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:Arial;font-size:12pt;">&#32;patented dietary supplement, the TrueScience</font><font style="font-family:Arial;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#8482;</sup></font><font style="font-family:Arial;font-size:12pt;">&#32;Anti-Aging Skin Care Regimen, Canine Health, and the AXIO</font><font style="font-family:Arial;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#8482;</sup></font><font style="font-family:Arial;font-size:12pt;">&#32;energy product line. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.</font></div><div style="line-height:138%;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:138%;padding-top:8px;text-align:left;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to" and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our leadership transition, future growth and distributor success. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investor Relations Contact:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Cindy England (801) 432-9036 <br>Director of Investor Relations <br>-or- <br>John Mills (646) 277-1254</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Partner, ICR INC</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><br><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lfvnq42015preannounce_image1.gif
<TEXT>
begin 644 lfvnq42015preannounce_image1.gif
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M#;4$#YK_0 5,0!S&P0/?X!JKNW;1*[VKVIV01+P^>SW#<+MX5QY+H+O$H@Z
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$ P( .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
